ROCKET PHARMACEUTICALS, INC. (RCKT) insider trading

By person

20 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Rtw Investments, LP entity

Director

—

18,188,457

$61.90M

0.0%

Gaurav Shah

CEO

—

1,056,594

$3.60M

+47.1%

Martin Wilson

General Counsel

—

598,489

$2.04M

+824.5%

Christopher James Stevens

Chief Operating Officer

—

505,784

$1.72M

—

Kinnari Patel

See Remarks

—

468,701

$1.59M

+16.4%

Gotham Makker

Director

—

415,346

$1.41M

+13.5%

Syed Ali-aamir Rizvi

Chief Medical Officer

—

407,874

$1.39M

—

Jonathan David Schwartz

See Remarks

—

299,064

$1.02M

+79.1%

Sarbani Chaudhuri

See Remarks

—

262,809

$894.34K

+65.0%

David P Southwell

Director

—

204,522

$695.99K

+12,221%

Aaron Ondrey

Chief Financial Officer

—

128,173

$436.17K

+174.0%

John Militello

See Remarks

—

89,780

$305.52K

+77.7%

Peter Fong

Director

—

76,195

$259.29K

—

Roderick Wong

Director

—

75,499

$256.92K

—

Mikael Dolsten

Director

—

67,082

$228.28K

—

Pedro P Granadillo

Director

—

54,734

$186.26K

—

Fady Ibraham Malik

Director

—

52,862

$179.89K

—

Carsten Boess

Director

—

52,862

$179.89K

—

Elisabeth Bjork

Director

—

50,000

$170.15K

—

Piratip Pratumsuwan

Director

—

30,000

$102.09K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

ROCKET PHARMACEUTICALS, INC.

What the insiders did No buying or selling

By person